NAGLU anticorps (C-Term)
Aperçu rapide pour NAGLU anticorps (C-Term) (ABIN5517086)
Antigène
Voir toutes NAGLU AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Séquence
- LEALVDSVAQ GIPFQQHQFD KNVFQLEQAF VLSKQRYPSQ PRGDTVDLAK
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the C terminal region of human NAGLU
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- NAGLU (N-Acetylglucosaminidase, alpha (NAGLU))
-
Autre désignation
- NAGLU
-
Sujet
-
This gene encodes an enzyme that degrades heparan sulfate by hydrolysis of terminal N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. This disease is characterized by the lysosomal accumulation and urinary excretion of heparan sulfate.
Alias Symbols: NAG, MPS3B, UFHSD, MPS-IIIB
Protein Size: 639 -
ID gène
- 4669
-
NCBI Accession
- NM_000263, NP_000254
-
UniProt
- P54802
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-